BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang Y, Lv QJ, Du QY, Yang BH, Lin RX, Wang SQ. Combined effects of Cantide and chemotherapeutic drugs on inhibition of tumor cells’ growth in vitro and in vivo. World J Gastroenterol 2005; 11(16): 2491-2496 [PMID: 15832424 DOI: 10.3748/wjg.v11.i16.2491]
URL: https://www.wjgnet.com/1007-9327/full/v11/i16/2491.htm
Number Citing Articles
1
O.H. Ozturk, H. Bozcuk, D. Burgucu, D. Ekinci, M. Ozdogan, S. Akca, M. Yildiz. Cisplatin cytotoxicity is enhanced with zoledronic acid in A549 lung cancer cell line: Preliminary results of an in vitro study. Cell Biology International 2007; 31(9) doi: 10.1016/j.cellbi.2007.02.004
2
M. I. Zvereva, T. S. Zatsepin, D. M. Azhibek, O. S. Shubernetskaya, O. V. Shpanchenko, O. A. Dontsova. Oligonucleotide inhibitors of telomerase: Prospects for anticancer therapy and diagnostics. Biochemistry (Moscow) 2015; 80(3) doi: 10.1134/S0006297915030013
3
Hua Wang, Qi-Rong Geng, Liang Wang, Yue Lu. Curcumin potentiates antitumor activity ofl-asparaginase via inhibition of the AKT signaling pathway in acute lymphoblastic leukemia. Leukemia & Lymphoma 2012; 53(7) doi: 10.3109/10428194.2011.649478
4
Kang Chen, Xiu Xin, Lipeng Qiu, Wenpan Li, Guannan Guan, Gang Li, Mingxi Qiao, Xiuli Zhao, Haiyang Hu, Dawei Chen. Co-delivery of p53 and MDM2 inhibitor RG7388 using a hydroxyl terminal PAMAM dendrimer derivative for synergistic cancer therapy. Acta Biomaterialia 2019; 100 doi: 10.1016/j.actbio.2019.09.041
5
Wang Guo-Bao, Chen Xiao-Qin, Geng Qi-Rong, Li Jie, Lin Gui-Nan, Lu Yue. Arsenic Trioxide overcomes cell adhesion-mediated drug resistance through down-regulating the expression of β1-integrin in K562 chronic myelogenous leukemia cell line. Leukemia & Lymphoma 2010; 51(6) doi: 10.3109/10428191003746315
6
Maria Lina Tornesello, Anna Lucia Tornesello, Noemy Starita, Andrea Cerasuolo, Francesco Izzo, Luigi Buonaguro, Franco Maria Buonaguro. Telomerase: a good target in hepatocellular carcinoma? An overview of relevant preclinical data. Expert Opinion on Therapeutic Targets 2022; 26(9) doi: 10.1080/14728222.2022.2147062
7
Zi-Qi Li, Guo-Song Zhang, Ri-Qun Liu, Shu-Yuan Shuai, Peng-Yi Hu, Qin Zheng, Shu-Hua Xiao. Anti-Glioma Effects of Ligustilide or n-Butylphthalide on Their Own and the Synergistic Effects with Temozolomide via PI3K/Akt Signaling Pathway. OncoTargets and Therapy 2023;  doi: 10.2147/OTT.S432901
8
Alessandro Allegra, Vanessa Innao, Giuseppa Penna, Demetrio Gerace, Andrea G. Allegra, Caterina Musolino. Telomerase and telomere biology in hematological diseases: A new therapeutic target. Leukemia Research 2017; 56 doi: 10.1016/j.leukres.2017.02.002
9
Ravinder Malik, Ipsita Roy. Design and development of antisense drugs. Expert Opinion on Drug Discovery 2008; 3(10) doi: 10.1517/17460441.3.10.1189
10
Lei He, Fei Zhong, Xing-Jun Chen, Ya-Ru Yang, Xue-Long Yan, Ming-Hui He, Xu Zhang, Mu-Zhen Wang, Yong-Qin Zeng, Qin-Feng Zhu, Zhu Zeng, Bo Tu, Qing-De Long, Yan Lin. A new phenolic compound from Persicaria capitata . Natural Product Research 2025; 39(14) doi: 10.1080/14786419.2024.2332485
11
Yuan Yuan, Hui Cai, Xiao-Jun Yang, Wei Li, Jin He, Tian-Kang Guo, Yi-Rong Chen. Liposome-mediated Induction of Apoptosis of Human Hepatoma Cells by C-Myc Antisense Phosphorothioate Oligodeoxynucleotide and 5-Fluorouracil. Asian Pacific Journal of Cancer Prevention 2014; 15(14) doi: 10.7314/APJCP.2014.15.14.5529
12
De‐Feng Shen, Shan‐Shan Wu, Rui‐Rui Wang, Qiang Zhang, Zhong‐Juan Ren, Hong Liu, Hua‐Dong Guo, Guang‐Gang Gao. A Silver(I)‐Estrogen Nanocluster: GSH Sensitivity and Targeting Suppression on HepG2 Cell. Small 2016; 12(44) doi: 10.1002/smll.201601936
13
Hongqiao Cai, Ruobing Wang, Xingren Guo, Meiyu Song, Fei Yan, Bai Ji, Yahui Liu. Combining Gemcitabine-Loaded Macrophage-like Nanoparticles and Erlotinib for Pancreatic Cancer Therapy. Molecular Pharmaceutics 2021; 18(7) doi: 10.1021/acs.molpharmaceut.0c01225
14
Jie Meng, Jianmin Xing, Yingze Wang, Juan Lu, Yuliang Zhao, Xueyun Gao, Paul C. Wang, Lee Jia, Xingjie Liang. Epigenetic modulation of human breast cancer by metallofullerenol nanoparticles: in vivo treatment and in vitro analysis. Nanoscale 2011; 3(11) doi: 10.1039/c1nr10898k